Protara Therapeutics, Inc. (TARA) Operating Lease, Right-of-Use Asset USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Protara Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2019 to 2024.
  • Protara Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $5.02 M, a 17% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $5.02 M -$1.03 M -17% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.26 M -$1.01 M -16.1% Dec 31, 2023 10-Q 2024-05-02
Q3 2023 $5.57 M -$939 K -14.4% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $5.81 M -$924 K -13.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $6.04 M -$909 K -13.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $6.28 M -$894 K -12.5% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $6.51 M -$907 K -12.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $6.73 M -$917 K -12% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $6.95 M +$5.92 M +570% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $7.17 M +$6.11 M +577% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $7.41 M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $7.65 M +$7.26 M +1891% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.04 M +$645 K +165% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.06 M Dec 31, 2020 10-K 2022-03-09
Q2 2020 $384 K +$316 K +465% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $392 K +$257 K +190% Mar 31, 2020 10-Q 2020-05-13
Q2 2019 $68 K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $135 K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.